City Therapeutics, Inc. (CTY)

CIK 2143850 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for City Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 26, 2026SCHEDULE 13G0000905148-26-004557
Oct 26, 2026SCHEDULE 13D0001193125-26-432028
Oct 22, 2026SCHEDULE 13G0002005369-26-000056
Oct 19, 202640001104659-26-116965
Oct 19, 202640001104659-26-116962
Oct 19, 20268-K0001104659-26-116947
Oct 19, 202640001104659-26-116959
Oct 19, 202640001104659-26-116956
Oct 19, 202640001104659-26-116966
Oct 19, 202640001104659-26-116958
Oct 19, 202640001104659-26-116963
Oct 16, 2026S-80001104659-26-116637
Oct 16, 2026424B40001104659-26-116636
Oct 15, 2026EFFECT9999999995-26-003256
Oct 15, 202630001104659-26-116350
Oct 15, 2026S-1MEF0001104659-26-116363
Oct 15, 202630001104659-26-116351
Oct 15, 202630001104659-26-116359
Oct 15, 202630001104659-26-116349
Oct 15, 202630001104659-26-116355
Oct 15, 202630001104659-26-116360
Oct 15, 202630001104659-26-116348
Oct 15, 202630001104659-26-116352
Oct 15, 202630001104659-26-116353
Oct 15, 2026CERT0001354457-26-000991